Literature DB >> 8918021

Media advocacy: lessons from community experiences.

D H Jernigan1, P A Wright.   

Abstract

Media advocacy is the strategic use of mass media and community organizing as a resource for advancing a social or public policy initiative. Across the United States, communities are using media advocacy to promote healthier public policies and environments. The U.S. Center for Substance Abuse Prevention commissioned numerous case studies of media advocacy on alcohol and tobacco issues in a diverse array of communities, including efforts in African-American and Latino communities or using computer-based electronic communication systems. The paper describes these efforts briefly, and summarizes lessons learned, including: media advocacy can lead to larger victories when used as a complement to community organizing in the context of a larger strategic vision for policy change; like policy advocacy, media advocacy is best done in the context of clear long-term goals; conscious framing, guiding the choice of spokespeople, visuals, and messages, can alter media coverage and public debate of health policies; advocates need to respect the media but also remember that they have power in relation to the media; and media advocacy is often controversial and not suited to every situation. The case studies show that media advocacy is a potent tool for public health workers, making an important contribution to campaigns to promote healthier public policies.

Entities:  

Mesh:

Year:  1996        PMID: 8918021

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  12 in total

1.  The spectrum of prevention: developing a comprehensive approach to injury prevention.

Authors:  L Cohen; S Swift
Journal:  Inj Prev       Date:  1999-09       Impact factor: 2.399

Review 2.  Investing in youth tobacco control: a review of smoking prevention and control strategies.

Authors:  P M Lantz; P D Jacobson; K E Warner; J Wasserman; H A Pollack; J Berson; A Ahlstrom
Journal:  Tob Control       Date:  2000-03       Impact factor: 7.552

3.  Press coverage of public expenditure of Master Settlement Agreement funds: how are non-tobacco control related expenditures represented?

Authors:  K M Clegg Smith; M A Wakefield; M Nichter
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

4.  Turning negative into positive: public health mass media campaigns and negative advertising.

Authors:  D E Apollonio; R E Malone
Journal:  Health Educ Res       Date:  2008-10-23

5.  Strategies for improving influenza immunization rates among hard-to-reach populations.

Authors:  David Vlahov; Micaela H Coady; Danielle C Ompad; Sandro Galea
Journal:  J Urban Health       Date:  2007-07       Impact factor: 3.671

6.  Rural print media portrayal of secondhand smoke and smoke-free policy.

Authors:  Donald W Helme; Mary Kay Rayens; Sarah E Kercsmar; Sarah M Adkins; Shelby J Amundsen; Erin Lee; Carol A Riker; Ellen J Hahn
Journal:  Health Promot Pract       Date:  2011-04-01

7.  A comparative content analysis of media reporting of sports betting in Australia: lessons for public health media advocacy approaches.

Authors:  Jennifer L David; Samantha L Thomas; Melanie Randle; Steven J Bowe; Mike Daube
Journal:  BMC Public Health       Date:  2017-11-14       Impact factor: 3.295

8.  A Public Health Approach to Tackling the Role of Culture in Shaping the Gun Violence Epidemic in the United States.

Authors:  Salma M Abdalla; Katherine M Keyes; Sandro Galea
Journal:  Public Health Rep       Date:  2020-10-27       Impact factor: 2.792

9.  Using public health and community partnerships to reduce density of alcohol outlets.

Authors:  David H Jernigan; Michael Sparks; Evelyn Yang; Randy Schwartz
Journal:  Prev Chronic Dis       Date:  2013-04-11       Impact factor: 2.830

10.  Reporting science and conflicts of interest in the lay press.

Authors:  Daniel M Cook; Elizabeth A Boyd; Claudia Grossmann; Lisa A Bero
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.